More about
Olaparib
News
June 03, 2023
2 min read
Save
Olaparib-durvalumab regimen prolongs PFS for certain women with advanced ovarian cancer
News
June 01, 2023
1 min read
Save
FDA approves Lynparza regimen for certain men with BRCA-positive prostate cancer
News
May 27, 2023
1 min read
Save
Durvalumab regimens extend PFS in advanced endometrial cancer
News
April 28, 2023
3 min read
Save
FDA committee favors restricting prostate cancer regimen to BRCA-positive subgroup
News
April 19, 2023
3 min read
Save
Combination therapy shows preliminary antitumor activity in pediatric neuroblastoma
News
March 27, 2023
2 min read
Save
Neoadjuvant olaparib feasible for women with germline-mutant ovarian cancer
News
February 01, 2023
2 min read
Save
Talazoparib may benefit patients with PALB2-mutated breast cancer
News
September 09, 2022
3 min read
Save
Olaparib regimen extends survival for certain women with advanced ovarian cancer
News
August 16, 2022
1 min read
Save
FDA grants priority review to Lynparza regimen for advanced prostate cancer
News
March 23, 2022
2 min read
Save